News Column

Agilent Technologies and PREMIER Biosoft Couple Hardware-Software Platforms to Advance Glycomics Research

June 17, 2014

Complementary Technologies Maximize Analytical Capabilities, Enable Researchers to Advance Discovery in Cancer, Other Complex Diseases

SANTA CLARA, Calif. & PALO ALTO, Calif.--(BUSINESS WIRE)-- Agilent Technologies, Inc. (NYSE:A) and PREMIER Biosoft today announced that a selection of Agilent’s high-resolution mass spectrometry and liquid chromatography instruments now supports PREMIER Biosoft’s SimGlycan software. The combined analytical strength of Agilent instrumentation and PREMIER Biosoft’s glycan and glycopeptide data analysis software will open up a new level of discovery for researchers studying the biology of disease.

Glycomics is the study of glycome structures (sugars, modified sugars and saccharides) in molecules and organisms, a tangled web of carbohydrates, proteins and lipids that modulate cellular function and play a primary role in the development of cancer, bacterial and viral diseases, and glycan-specific hereditary diseases. These structures are very difficult to study due to their complexity and kinetics.

“Agilent and PREMIER Biosoft are focused on solving the glycan and glycopeptide identification problem in biopharmaceutical analyses,” said PREMIER Biosoft CEO Arun Apte. “Combining our powerful instruments and software will enable researchers to generate, process and analyze highly complex data so they can put it to use in drug development.”

“Used together, our powerful instrumentation and software fulfills a major unmet need for customers in biopharmaceutical research and development laboratories,” said David Edwards, Agilent’s senior director of LC/MS marketing.

For more information on Agilent’s LC/MS solutions, please click here.

Information on SimGlycan software is available athttp://premierbiosoft.com/glycan/index.html.

Agilent and PREMIER Biosoft also offer a combined hardware-software solution for lipidomics research.

About PREMIER Biosoft

PREMIER Biosoft (www.premierbiosoft.com) was founded in 1994. The company is led by computer scientists, statisticians and biologists dedicated to producing cutting-edge intuitive software for research in life sciences. The company’s goal is to study the most recent innovations in life sciences and translate them into software products to aid research. Follow PREMIER Biosoft on Twitter @PREMIERBiosoft and on Facebook.

About Agilent Technologies

Agilent Technologies Inc. (NYSE:A) is the world’s premier measurement company and a technology leader in chemical analysis, life sciences, diagnostics, electronics and communications. The company’s 20,600 employees serve customers in more than 100 countries. Agilent had revenues of $6.8 billion in fiscal 2013. Information about Agilent is available at www.agilent.com.

On Sept. 19, 2013, Agilent announced plans to separate into two publicly traded companies through a tax-free spinoff of its electronic measurement business. The new company is named Keysight Technologies, Inc. The separation is expected to be completed in early November 2014.

NOTE TO EDITORS: Further technology, corporate citizenship and executive news is available at www.agilent.com/go/news.



Agilent Technologies, Inc.

Susan Berg, +1 408-553-7093

susan_berg1@agilent.com

or

PREMIER Biosoft

Shonali Paul, +1 650-856-2703

shonali@premierbiosoft.com


Source: Agilent Technologies, Inc.


For more stories covering the world of technology, please see HispanicBusiness' Tech Channel



Source: Business Wire


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters